GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $179,000 | +7.8% | 4,116 | +7.8% | 0.01% | +25.0% |
| Q1 2022 | $166,000 | -1.2% | 3,817 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $168,000 | +15.1% | 3,817 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $146,000 | -18.9% | 3,817 | -15.7% | 0.00% | 0.0% |
| Q2 2021 | $180,000 | +10.4% | 4,527 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $163,000 | -8.9% | 4,577 | -6.2% | 0.00% | -20.0% |
| Q4 2020 | $179,000 | -7.3% | 4,877 | -5.1% | 0.01% | -16.7% |
| Q3 2020 | $193,000 | +4.3% | 5,137 | +13.5% | 0.01% | 0.0% |
| Q2 2020 | $185,000 | -14.7% | 4,527 | -21.1% | 0.01% | -33.3% |
| Q1 2020 | $217,000 | +14.2% | 5,739 | +41.6% | 0.01% | +50.0% |
| Q4 2019 | $190,000 | +12.4% | 4,052 | +2.5% | 0.01% | 0.0% |
| Q3 2019 | $169,000 | +23.4% | 3,952 | +15.7% | 0.01% | +20.0% |
| Q2 2019 | $137,000 | -42.2% | 3,417 | -42.0% | 0.01% | -54.5% |
| Q3 2018 | $237,000 | 0.0% | 5,890 | 0.0% | 0.01% | +10.0% |
| Q2 2018 | $237,000 | +3.0% | 5,890 | 0.0% | 0.01% | +11.1% |
| Q1 2018 | $230,000 | +9.5% | 5,890 | -0.7% | 0.01% | +12.5% |
| Q4 2017 | $210,000 | -12.1% | 5,934 | +0.7% | 0.01% | -20.0% |
| Q3 2017 | $239,000 | -13.4% | 5,890 | -7.9% | 0.01% | -16.7% |
| Q2 2017 | $276,000 | -0.7% | 6,392 | -3.0% | 0.01% | -7.7% |
| Q1 2017 | $278,000 | +18.3% | 6,592 | +8.2% | 0.01% | +18.2% |
| Q4 2016 | $235,000 | -10.6% | 6,090 | 0.0% | 0.01% | -15.4% |
| Q3 2016 | $263,000 | -22.0% | 6,090 | -21.6% | 0.01% | -23.5% |
| Q2 2016 | $337,000 | -6.4% | 7,770 | -12.3% | 0.02% | -10.5% |
| Q1 2016 | $360,000 | -22.6% | 8,863 | -23.1% | 0.02% | -20.8% |
| Q4 2015 | $465,000 | +7.1% | 11,531 | +2.2% | 0.02% | 0.0% |
| Q3 2015 | $434,000 | -9.6% | 11,286 | -2.0% | 0.02% | 0.0% |
| Q2 2015 | $480,000 | -9.8% | 11,517 | 0.0% | 0.02% | -11.1% |
| Q1 2015 | $532,000 | +6.0% | 11,517 | -2.0% | 0.03% | +8.0% |
| Q4 2014 | $502,000 | -1.0% | 11,752 | +6.5% | 0.02% | -3.8% |
| Q3 2014 | $507,000 | -21.3% | 11,034 | -8.4% | 0.03% | -21.2% |
| Q2 2014 | $644,000 | -2.4% | 12,046 | -2.5% | 0.03% | -5.7% |
| Q1 2014 | $660,000 | +13.2% | 12,361 | +13.1% | 0.04% | +12.9% |
| Q4 2013 | $583,000 | +4.5% | 10,926 | -1.8% | 0.03% | -3.1% |
| Q3 2013 | $558,000 | +0.4% | 11,126 | 0.0% | 0.03% | -3.0% |
| Q2 2013 | $556,000 | – | 11,126 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |